Cargando…

Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) results from increased hepatic total cholesterol (TC) and total triglyceride (TG) accumulation. In our previous study, we found that rats treated with hyperoside became resistant to hepatic lipid accumulation. OBJECTIVES: The present study aims...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Songsong, Sheng, Feiya, Zou, Liang, Xiao, Jianbo, Li, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655136/ https://www.ncbi.nlm.nih.gov/pubmed/35024184 http://dx.doi.org/10.1016/j.jare.2021.06.001

Ejemplares similares

Metabolic Engineering of Escherichia coli for Hyperoside Biosynthesis
por: Li, Guosi, et al.
Publicado: (2022)

Alcohol Induces More Severe Fatty Liver Disease by Influencing Cholesterol Metabolism
por: Li, Bo, et al.
Publicado: (2019)

Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats
por: Yu, Jae Young, et al.
Publicado: (2018)

Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver
por: Thapa, Keshav, et al.
Publicado: (2023)

Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
por: Huang, Jizhen, et al.
Publicado: (2020)

Regulation of Bile Acid and Cholesterol Metabolism by PPARs
por: Li, Tiangang, et al.
Publicado: (2009)

Metabolism of Cholesterol and Bile Acids by the Gut Microbiota
por: Gérard, Philippe
Publicado: (2013)

Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
por: Yang, Chao, et al.
Publicado: (2021)

Retraction Note: Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats
por: Yu, Jae Young, et al.
Publicado: (2020)

Alcohol and Metabolic-associated Fatty Liver Disease
por: Sun, Fu-Rong, et al.
Publicado: (2021)

High dietary cholesterol and ovariectomy in rats repress gene expression of key markers of VLDL and bile acid metabolism in liver
por: Farahnak, Zahra, et al.
Publicado: (2015)

Regulation of Cholesterol Metabolism by Phytochemicals Derived from Algae and Edible Mushrooms in Non-Alcoholic Fatty Liver Disease
por: Eilam, Yahav, et al.
Publicado: (2022)

Betaine attenuates chronic alcohol-induced fatty liver by broadly regulating hepatic lipid metabolism
por: Yang, Wenjuan, et al.
Publicado: (2017)

Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
por: Lu, Yifei, et al.
Publicado: (2022)

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
por: Mouzaki, Marialena, et al.
Publicado: (2016)

Bile acids and sphingolipids in non-alcoholic fatty liver disease
por: Jackson, Kaitlyn G., et al.
Publicado: (2022)

Bile Acid and Cholesterol Metabolism in Atherosclerotic Cardiovascular Disease and Therapy
por: Chiang, John Y. L., et al.
Publicado: (2020)

Special Issue: Microbial Impact on Cholesterol and Bile Acid Metabolism
por: Ridlon, Jason M.
Publicado: (2022)

Metabolic Profiling of Bile Acids in the Urine of Patients with Alcohol‐Associated Liver Disease
por: He, Liqing, et al.
Publicado: (2021)

Systematic Identification, Fragmentation Pattern, And Metabolic Pathways of Hyperoside in Rat Plasma, Urine, And Feces by UPLC-Q-Exactive Orbitrap MS
por: Ji, Li, et al.
Publicado: (2022)

Perilla Oil Supplementation Ameliorates High-Fat/High-Cholesterol Diet Induced Nonalcoholic Fatty Liver Disease in Rats via Enhanced Fecal Cholesterol and Bile Acid Excretion
por: Chen, Ting, et al.
Publicado: (2016)

Experimental models of metabolic and alcoholic fatty liver disease
por: Buyco, Delfin Gerard, et al.
Publicado: (2021)

Metabolic drivers of non-alcoholic fatty liver disease
por: Bence, Kendra K., et al.
Publicado: (2020)

Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids
por: Naito, Yuji, et al.
Publicado: (2020)

The effect of exercise training on upregulation of molecular markers of bile acid metabolism in the liver of ovariectomized rats fed a cholesterol-rich diet
por: Farahnak, Zahra, et al.
Publicado: (2017)

Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
por: Lin, Chuan-Hao, et al.
Publicado: (2018)

Intestinal Bacteria Interplay With Bile and Cholesterol Metabolism: Implications on Host Physiology
por: Molinero, Natalia, et al.
Publicado: (2019)

Hyperoside attenuates dextran sulfate sodium-induced colitis in mice possibly via activation of the Nrf2 signalling pathway
por: Yang, Lei, et al.
Publicado: (2017)

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
por: Malhotra, Pooja, et al.
Publicado: (2020)

Vitamin C and vitamin D(3) alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis
por: Chen, Qingling, et al.
Publicado: (2023)

Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
por: Wang, Jieyi, et al.
Publicado: (2022)

The metabolic adaptation of bile acids and cholesterol after biliary atresia in lamprey via transcriptome-based analysis
por: Zhang, Qipeng, et al.
Publicado: (2023)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Hyperoside as a Potential Natural Product Targeting Oxidative Stress in Liver Diseases
por: Jang, Eungyeong
Publicado: (2022)

Metabolic profiling of adolescent non-alcoholic fatty liver disease
por: Hartley, April, et al.
Publicado: (2019)

Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease
por: El Hadi, Hamza, et al.
Publicado: (2019)

Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease
por: Zhang, Lijia, et al.
Publicado: (2022)

Coordinate Regulation of Cholesterol and Bile Acid Metabolism by the Clock Modifier Nobiletin in Metabolically Challenged Old Mice
por: Nohara, Kazunari, et al.
Publicado: (2019)

Hyperoside attenuates renal aging and injury induced by D-galactose via inhibiting AMPK-ULK1 signaling-mediated autophagy
por: Liu, Buhui, et al.
Publicado: (2018)

Protective effects of quercetin and hyperoside on renal fibrosis in rats with unilateral ureteral obstruction
por: YAN, YANG, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v5u24npps60ro236g7rp1ej5hu